At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
continuous positive airway pressuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Continuous Positive Airway Pressure for Treatment of Obstructive Sleep Apnea on Drug-resistant Hypertension : A Randomized Controlled Trial
In Brief
A clinical study evaluating continuous positive airway pressure for Resistant Hypertension and Obstructive Sleep Apnea. Completed, enrolled 92 participants across 1 site.
Detailed Summary
The objectives of this study are to investigate the effect of continuous positive airway pressure (CPAP) treatment on blood pressure control and vascular inflammation in subjects with resistant hypertension and moderate obstructive sleep apnea (OSA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsResistant Hypertension, Obstructive Sleep Apnea
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2009
First PostedApr 2009
Primary CompletionJul 2019
TodayJul 2026
First PostedApr 16, 2009
Enrollment StartMar 1, 2009
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 10.3 yearsPosted 17.2 years ago
Interventions
continuous positive airway pressuredevice
Use CPAP whenever sleep